Kirkland Represents Covetrus on $250 Million Convertible Preferred Equity Investment by Clayton, Dubilier & Rice

Kirkland & Ellis advised Covetrus (NASDAQ: CVET), a global leader in animal-health technology and services, on a $250 million convertible preferred equity investment from Clayton, Dubilier & Rice, a leading private equity firm that has been a significant shareholder of the Company. The additional capital will significantly strengthen the Company’s financial profile and enable management to execute on its strategic growth objectives.

Read the Covetrus press release

The Kirkland team was led by transactional partner David Feirstein and capital markets partner Ross Leff and corporate partner Keri Schick Norton and associate Arlene Ortiz-Leytte and tax partners Dean Shulman and Benjamin Schreiner and associate Vivek Ratnam.